Yuzhe Yang,Yuan Yuan,Guo Zhang,Hao Wang,Yingcong Chen,Yingcheng Liu,Christopher G. Tarolli,Daniel Crepeau,Jan Bukartyk,Mithri R. Junna,Aleksandar Videnović,Terry D. Ellis,Melissa C. Lipford,Ray Dorsey,Dina Katabi
出处
期刊:Nature Medicine [Springer Nature] 日期:2022-08-22卷期号:28 (10): 2207-2215被引量:163
There are currently no effective biomarkers for diagnosing Parkinson's disease (PD) or tracking its progression. Here, we developed an artificial intelligence (AI) model to detect PD and track its progression from nocturnal breathing signals. The model was evaluated on a large dataset comprising 7,671 individuals, using data from several hospitals in the United States, as well as multiple public datasets. The AI model can detect PD with an area-under-the-curve of 0.90 and 0.85 on held-out and external test sets, respectively. The AI model can also estimate PD severity and progression in accordance with the Movement Disorder Society Unified Parkinson's Disease Rating Scale (R = 0.94, P = 3.6 × 10